Palmitoylethanolamide (PEA) is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acylethanolamines family of lipid mediators

  • PEA is a clinically trialled ingredient
  • Presented in a coconut-derived (MCT) lipid suspension
  • 1mL contains 300mg PEA for easy dose calculation
  • Synthesised from palmitic acid from sustainably sourced palm oil
  • PEA liquid contains 99% pure PEA, which has been confirmed by purity testing
  • Pleasant natural orange flavour

Dosage & warnings

28 drops (1 mL)

Only take as directed.


Palmitoylethanolamide (PEA) 300 mg